The study revealed high mutations of epigenetic regulators: KMT2D (67%), KMT2C (58%), SETD2 (50%), KMT2A (33%), and KAT6A (33%), in metastatic cSCC [18]. This evidence concerns the gene KMT2C and skin squamous cell carcinoma.